1-2 of 2
Homer A Macapinlac, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mature Results of BEAM/High-Dose Rituximab Vs BEAM/Yttrium-90 Ibritumomab Tiuxetan (Zevalin ® ) and Autologous Stem Cell Transplantation (ASCT) for Relapsed CD20+ Follicular and Diffuse Large B-Cell Lymphoma: Survival Outcomes and Risk of Secondary Malignancies

Lisa Zipp, MS, Rima M Saliba, Ph.D., Rosamar Valverde, Grace-Julia Okoroji, Martin Korbling, MD, Barry I Samuels, MD, Lynne V. Abruzzo, MD, PhD, Amin M Alousi, MD, Borje S Andersson, MD, PhD, Chitra M Hosing, MD, Bill Erwin, MS, Paolo Anderlini, MD, Uday R Popat, MD, Partow Kebriaei, Homer A Macapinlac, MD, Richard Champlin, MD, Issa F. Khouri, MD
Journal: Blood
Blood (2011) 118 (21): 2005.
https://doi.org/10.1182/blood.V118.21.2005.2005
Published: 2011
Journal Articles

Nonmyeloablative Allogeneic Stem Cell Transplantation with/ or without 90 yttrium Ibritumomab Tiuxetan ( 90 YIT) Is Curative for Relapsed Follicular Lymphoma: Median 9 Year Follow-up Results

Issa F Khouri, MD, Rima M Saliba, Ph.D., Rosamar Valverde, Barry I Samuels, MD, Martin Korbling, MD, Amin M Alousi, MD, Paolo Anderlini, MD, Qaiser Bashir, MD, Marcos De Lima, MD, Chitra Hosing, MD, Partow Kebriaei, MD, Yago Nieto, MD, PhD, Uday R Popat, MD, Muzaffar Qazilbash, MD, Sattva Neelapu, MD, Nathan H. Fowler, MD, Felipe Samaniego, MD, Luhua Wang, MD, Richard Champlin, MD, Homer A Macapinlac, MD
Journal: Blood
Blood (2011) 118 (21): 662.
https://doi.org/10.1182/blood.V118.21.662.662
Published: 2011